Skip to content

The effects of moisturizer containing licochalcone A, 1,2-decanediol, L-carnitine, and salicylic acid on facial sebum characteristics in oily skin subjects: a pilot study

The effects of moisturizer containing licochalcone A, 1,2-decanediol, L-carnitine, and salicylic acid on facial sebum characteristics in oily skin subjects: a pilot study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210531002
Enrollment
20
Registered
2021-05-31
Start date
2021-06-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oily facial skin subjects Sebum analysis, licochalcone A, 1,2-decanediol, L-carnitine, salicylic acid, oily skin, facial sebum

Interventions

Moisturizer containing licochalcone A,1 2 decanediol, L carnitine, and salicylic acid is a cosmeceutical product (medical skin care). Subjects regularly apply 1 fingertip (equivalent to 2.5 grams) of
Experimental Other
Moisturizer containing licochalcone A, 1 2 decanediol, Lcarnitine, and salicylic acid

Sponsors

Beiersdorf Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Healthy men or women with the age of 18 to 40 years old. 2. Subjects are assessed by the dermatologist to have oily facial skin with sebum amount more than 105 microgram/cm2 measured by Sebumeter. 3. Participants must willingly give informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects with underlying diseases such as cardiac disease, liver disease or kidney disease, or currently taking medications for health issue 2. History of allergic reaction to any components of the product 3. Subjects who have rash or other dermatologic diseases on their faces 4. History of systemic acne treatment including isotretinoin and spironolactone use within 3 months before study enrollment 5. History of oral contraceptives or anti-androgenic drug use within 3 months before study enrollment 6. History of dermatologic procedural treatment within 6 months before study enrollment. 7. History of topical corticosteroid use on the face within 2 weeks and systemic corticosteroid within 4 weeks before study enrollment 8. Female subjects who are currently pregnant, breastfeeding, or having a plan to get pregnant. If pregnancy is suspected, pregnancy test must be performed before enrollment.

Design outcomes

Primary

MeasureTime frame
Reduction in facial skin surface lipid amount after the application of moisturizer containing licochalcone A, 1,2-decanediol, L-carnitine, and salicylic acid baseline, week 2,4, 6 and 8 Sebumeter(quantitative),Qualitative changes in facial lipid profilesafter the application of moisturizer containing licochalcone A, 1,2-decanediol, L-carnitine, and salicylic acid baseline, week 2,4, 6 and 8 Facial sebum analysis by gas chromatography-mass spectrometry (qualitative)

Secondary

MeasureTime frame
Side effects of moisturizer containing licochalcone A, decanediol, L-carnitine, and salicylic acid week 2,4,6 and 8 Side effects such as erythema, dryness, scaling, stinging, burning and pruritus will be measured by 4-point grading scores,Patients' satisfaction of moisturizer containing licochalcone A, decanediol, L-carnitine, and salicylic acid week8 Satisfaction is evaluated by overall VAS score

Countries

Thailand

Contacts

Public ContactChanat Kumtornrut

Division of Dermatology, Faculty of Medicine, Chulalongkorn university

chanat_1@yahoo.com66814594965

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026